1. Home
  2. CDNA vs HTZ Comparison

CDNA vs HTZ Comparison

Compare CDNA & HTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDNA
  • HTZ
  • Stock Information
  • Founded
  • CDNA 1998
  • HTZ 1918
  • Country
  • CDNA United States
  • HTZ United States
  • Employees
  • CDNA N/A
  • HTZ N/A
  • Industry
  • CDNA Medical Specialities
  • HTZ Rental/Leasing Companies
  • Sector
  • CDNA Health Care
  • HTZ Consumer Discretionary
  • Exchange
  • CDNA Nasdaq
  • HTZ Nasdaq
  • Market Cap
  • CDNA 1.0B
  • HTZ 2.0B
  • IPO Year
  • CDNA 2014
  • HTZ 1997
  • Fundamental
  • Price
  • CDNA $19.49
  • HTZ $7.17
  • Analyst Decision
  • CDNA Buy
  • HTZ Sell
  • Analyst Count
  • CDNA 6
  • HTZ 8
  • Target Price
  • CDNA $30.33
  • HTZ $4.45
  • AVG Volume (30 Days)
  • CDNA 982.3K
  • HTZ 6.8M
  • Earning Date
  • CDNA 07-30-2025
  • HTZ 08-07-2025
  • Dividend Yield
  • CDNA N/A
  • HTZ N/A
  • EPS Growth
  • CDNA N/A
  • HTZ N/A
  • EPS
  • CDNA 1.07
  • HTZ N/A
  • Revenue
  • CDNA $346,421,000.00
  • HTZ $8,782,000,000.00
  • Revenue This Year
  • CDNA $13.31
  • HTZ N/A
  • Revenue Next Year
  • CDNA $15.46
  • HTZ $2.42
  • P/E Ratio
  • CDNA $17.54
  • HTZ N/A
  • Revenue Growth
  • CDNA 25.92
  • HTZ N/A
  • 52 Week Low
  • CDNA $14.09
  • HTZ $2.47
  • 52 Week High
  • CDNA $34.84
  • HTZ $9.39
  • Technical
  • Relative Strength Index (RSI)
  • CDNA 57.30
  • HTZ 58.27
  • Support Level
  • CDNA $18.64
  • HTZ $6.60
  • Resistance Level
  • CDNA $19.84
  • HTZ $8.03
  • Average True Range (ATR)
  • CDNA 0.83
  • HTZ 0.47
  • MACD
  • CDNA -0.05
  • HTZ 0.09
  • Stochastic Oscillator
  • CDNA 69.64
  • HTZ 62.77

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About HTZ Hertz Global Holdings Inc

Hertz Global Holdings Inc is engaged principally in the business of renting vehicles through Hertz, Dollar and Thrifty brands. The Company has identified two reportable segments: Americas RAC: Rental of vehicles, as well as sales of vehicles and value-added services, in the U.S., Canada, Latin America and the Caribbean; International RAC: Rental of vehicles, as well as sales of vehicles and value-added services, in locations other than the U.S., Canada, Latin America and the Caribbean. The Company maintain a substantial network of company-operated rental locations, a majority of which are in Europe, and have franchisees and partners that operate rental locations under brands. Geographical markets includes U.S., Europe, Pacific Asia, Middle East and Africa, Latin America.

Share on Social Networks: